GPER1 and ovarian cancer: These findings are consistent with previous studies showing that GPER selective agonists disrupt spindle formation and thus arrest cell cycle at prophase of mitosis in ovarian cancer [31], and induce caspase- dependent and independent programmed cell death [61,62].